Open access
Venetoclax plus hypomethylating agent improves response rates but not survival in TP53-mutated myelodysplastic syndromes
Michael Canonico
Parth C. Patel
N. Al Ali
A. Kishtagari
Kateryna Fedorov
Hayley J. Hawkins
Katherine J. Walsh
Kathryn Kennedy
Erica Mittlebeeler
Sarah Profitt
Callee M. Brooks
Laura A. Lee
Sanjay R. Mohan
E. Mason
R. Komrokji
M. Savona
D. Sallman
S. Ball
Medicine
Abstract
,